Two is Better Than One: A Novel Venous Access System for Intermittent Apheresis
NCT ID: NCT04846374
Last Updated: 2023-05-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2021-05-26
2023-04-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants: 20 participants at UNC who were referred for change from a vortex port to a powerflow port.
Procedures (methods): Placement of one of two configurations of the powerflow port and follow up visits between January 1, 2019 and December 31, 2023.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter
NCT03987321
A Safety and Efficacy Study for Implantation and Retrieval Procedures Using the VENATECH® Retrieval Filter System
NCT02674672
Use of the Venous Coupler in Breast Reconstruction by Means of a Deep Inferior Epigastric Perforator: Reduction of Surgery Length and Venous Thromboses ?
NCT03340623
Functional Evaluation of Two Types of Totally Implanted Venous Ports
NCT00484848
Vascular Access Complications for Therapeutic Apheresis in Nephrology
NCT05894317
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PowerPort Subjects
This study will involve a chart review of patients at UNC who were referred for change from a vortex port to a powerflow port.
PowerPort
The study will compare pheresis sessions with the old system versus pheresis sessions with one of two new configurations.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PowerPort
The study will compare pheresis sessions with the old system versus pheresis sessions with one of two new configurations.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Referred for change from a vortex port to a powerflow port.
* Previously placed or scheduled placement of one of two configurations of the PowerFlow port
Exclusion Criteria
* Unable to provide informed consent.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of North Carolina, Chapel Hill
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Bream, MD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Howlett MS, Hicks K, Park Y, Karafin MS, Bream PR Jr. Use of a novel configuration of ports for patients needing intermittent long-term apheresis. J Clin Apher. 2024 Aug;39(4):e22143. doi: 10.1002/jca.22143.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21-0287
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.